ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1657

Does Advanced Age Influence the Type of Renal Injury and the Prognosis of Lupus Nephritis?

Eulalia Armengol1, Javier Narváez2, Helena Borrell1, Sergi Heredia1, Milagros Ricse1, Eva Benavent3, Alex Roset3, Carmen Gomez Vaquero1, Joan Torras4, Francesca Mitjavila3 and Joan Miquel Nolla1, 1Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 2Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, 3Internal Medicine, Hospital Universitario de Bellvitge, Barcelona, Spain, 4Nephrology, Hospital Universitario de Bellvitge, Barcelona, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Nephritis, outcome measures and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Biomarker, Translational and Nephritis Studies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease that usually affects young people. Several reviews have shown that age may have an effect on the clinical expression of the disease and have suggested that in terms of its presentation and clinical course late-onset SLE is generally less severe. Although there is no unanimous agreement, most authors take late onset SLE to refer to disease occurring after age 50. Our objetive was to examine whether advanced age influences the type of histological lesions and prognosis of lupus nephritis.

Methods: The sample comprised 243 patients with SLE treated between 1980 and 2013 at a tertiary university hospital that does not attend pediatric populations. Patients were registered in a specific database. Patients with lupus nephritis confirmed by renal biopsy and follow-up time of at least two years (n = 79) were selected for analysis. Patients were divided into two groups according to age: over 50 (n = 30) and under 50 (n = 49). “Responders” were defined as patients who presented remission (partial or complete) after completing induction therapy, and “non-responders” were patients in whom no improvement was observed in the analytical parameters, those with histological transformation, and those who died of causes related to nephritis.The Student t test was used to compare continuous variables between groups, or the Mann-Whitney test when variables were not normally distributed. To compare qualitative variables the chi-square or Fisher’s exact test was used when the expected frequency was less than 5. The level of significance was set at p < 0.05.

Results: In the 79 patients (64 women), mean age at the time of diagnosis of nephritis was 45 years ± 14 (range 17-80) and mean time since onset of SLE was 15.9 months (range 0 – 456). In 81% (64/79) of cases, renal disease was present at the time of diagnosis or during the first year of follow-up. The mean SLEDAI score was 15 ± 7.6. The main results of the comparative study between age groups are shown in the following table:

 

Age

≤ 50 years

(N = 49)

 

Age

 > 50 years

(N = 30)

p

Sex (male/female)

Evolution course of SLE in months (median)

Lupus nephritis Class II

Lupus nephritis Class III

Lupus nephritis Class IV-S

Lupus nephritis Class IV-G

Lupus nephritis Class V

Activity Index (mean ± SD)

Chronicity Index  (mean ± SD)

Responders / No responders

Development of renal insufficiency

 

11/38

2 (0-230)

7 (14%)

10 (20%)

12 (24.5%)

13 (26.5%)

7 (14%)

7.8 ± 4.5

1.5 ± 1.5

40 (82%)/ 9 (18%)

7 (14.3%)

 

4/26

1 (0-456)

7 (23%)

4 (13%)

5 (17%)

9 (30%)

5 (17%)

6 ± 4

1.3 ± 1.9

24 (80%)  / 6 (20%)

3 (10%)

 0.268

0.504

0.363

0.367

0.349

0.850

0.852

0.151

0.467

0.121

0.114

No significant differences were observed between age groups in either the type of renal injury or prognosis.

With regard to treatment, no differences were observed in the percentage of patients who were given hydroxychloroquine, corticosteroids or immunosuppressants, but the use of statins (p = 0.038) and ACE inhibitors (p = 0.033) was higher in the over 50s group.

Conclusion: Advanced age does not determine the type of histological lesion, nor does it appear to be a poor prognostic factor in lupus nephritis.


Disclosure:

E. Armengol,
None;

J. Narváez,
None;

H. Borrell,
None;

S. Heredia,
None;

M. Ricse,
None;

E. Benavent,
None;

A. Roset,
None;

C. Gomez Vaquero,
None;

J. Torras,
None;

F. Mitjavila,
None;

J. M. Nolla,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-advanced-age-influence-the-type-of-renal-injury-and-the-prognosis-of-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology